Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine versus Verapamil in Paroxysmal Supraventricular Tachycardia (PSVT)
IRCT20200202046343N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of adenosine and verapamil in paroxysmal supraventricular tachycardia (PSVT) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
adenosineverapamil
03
Conditions
paroxysmal supraventricular tachycardia (PSVT)
Beyond the preview
Go deeper on IRCT20200202046343N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200202046343N1.